Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1999 Nov;89(11):1684–1689. doi: 10.2105/ajph.89.11.1684

Progress in coverage with hepatitis B vaccine among US children, 1994-1997.

H R Yusuf 1, V G Coronado 1, F A Averhoff 1, E F Maes 1, L E Rodewald 1, M P Battaglia 1, F J Mahoney 1
PMCID: PMC1508968  PMID: 10553389

Abstract

OBJECTIVES: This study was done to assess progress in hepatitis B vaccination of children from 1994 through 1997. METHODS: We used data from the National Immunization Survey (NIS), a random-digit-dialed telephone survey that includes a mail survey to verify vaccination providers' records. The NIS is conducted in 78 geographic areas (50 states and 28 selected urban areas) in the United States. RESULTS: A total of 32,433 household interviews were completed in the 1997 NIS. An estimated 83.7% of children aged 19 to 35 months received 3 or more doses of hepatitis B vaccine. Coverage with 3 doses was greater (86.7%) among children in states that had day care entry requirements for hepatitis B vaccination than among children in states without such requirements (83.0%) and was greater among children from families with incomes at or above the poverty level (85.0%) than among children below the poverty level (80.6%). Hepatitis B vaccination of children increased from 1994 through 1996, from 41% to 84%, but coverage reached a constant level of 84% to 85% in 1996/97. CONCLUSION: Although substantial progress has been made in fully vaccinating children against hepatitis B, greater efforts are needed to ensure that all infants receive 3 doses of hepatitis B vaccine.

Full text

PDF
1684

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Freed G. L., Bordley W. C., Clark S. J., Konrad T. R. Reactions of pediatricians to a new Centers for Disease Control recommendation for universal immunization of infants with hepatitis B vaccine. Pediatrics. 1993 Apr;91(4):699–702. [PubMed] [Google Scholar]
  2. Freed G. L., Freeman V. A., Clark S. J., Konrad T. R., Pathman D. E. Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization. J Fam Pract. 1996 Jun;42(6):587–592. [PubMed] [Google Scholar]
  3. Ganiats T. G., Bowersox M. T., Ralph L. P. Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early? J Fam Pract. 1993 Feb;36(2):147–149. [PubMed] [Google Scholar]
  4. Halsey N. A. Discussion of Immunization Practices Advisory Committee/American Academy of Pediatrics recommendations for universal infant hepatitis B vaccination. Pediatr Infect Dis J. 1993 May;12(5):446–449. doi: 10.1097/00006454-199305000-00038. [DOI] [PubMed] [Google Scholar]
  5. LeBaron C. W., Chaney M., Baughman A. L., Dini E. F., Maes E., Dietz V., Bernier R. Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA. 1997 Feb 26;277(8):631–635. [PubMed] [Google Scholar]
  6. Mahoney F. J., Woodruff B. A., Erben J. J., Coleman P. J., Reid E. C., Schatz G. C., Kane M. A. Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection. J Infect Dis. 1993 Jan;167(1):203–207. doi: 10.1093/infdis/167.1.203. [DOI] [PubMed] [Google Scholar]
  7. McMahon B. J., Rhoades E. R., Heyward W. L., Tower E., Ritter D., Lanier A. P., Wainwright R. B., Helminiak C. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives. Lancet. 1987 Nov 14;2(8568):1134–1136. doi: 10.1016/s0140-6736(87)91557-1. [DOI] [PubMed] [Google Scholar]
  8. Pathman D. E., Konrad T. R., Freed G. L., Freeman V. A., Koch G. G. The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations. Med Care. 1996 Sep;34(9):873–889. doi: 10.1097/00005650-199609000-00002. [DOI] [PubMed] [Google Scholar]
  9. Poovorawan Y., Sanpavat S., Pongpunlert W., Chumdermpadetsuk S., Sentrakul P., Safary A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA. 1989 Jun 9;261(22):3278–3281. [PubMed] [Google Scholar]
  10. Shapiro C. N., Margolis H. S. Impact of hepatitis B virus infection on women and children. Infect Dis Clin North Am. 1992 Mar;6(1):75–96. [PubMed] [Google Scholar]
  11. Stevens C. E., Taylor P. E., Tong M. J., Toy P. T., Vyas G. N., Nair P. V., Weissman J. Y., Krugman S. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA. 1987 May 15;257(19):2612–2616. doi: 10.1001/jama.257.19.2612. [DOI] [PubMed] [Google Scholar]
  12. Woodruff B. A., Stevenson J., Yusuf H., Kwong S. L., Todoroff K. P., Hadler J. L., Hoyt M. A., Mahoney F. J. Progress toward integrating hepatitis B vaccine into routine infant immunization schedules in the United States, 1991 through 1994. Connecticut Hepatitis B Project Group. Pediatrics. 1996 Jun;97(6 Pt 1):798–803. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES